Clovis Oncology, Inc.·4

Mar 18, 4:53 PM ET

BLAIR JAMES C 4

4 · Clovis Oncology, Inc. · Filed Mar 18, 2019

Insider Transaction Report

Form 4
Period: 2019-03-14
BLAIR JAMES C
Director10% Owner
Transactions
  • Other

    Common Stock

    2019-03-18+70110,105 total(indirect: By Susan W. and James C. Blair Family L.P.)
  • Sale

    Common Stock

    2019-03-14$27.79/sh17,056$473,9860 total(indirect: By DP VII Associates, L.P.)
  • Other

    Common Stock

    2019-03-1810,0000 total(indirect: By LLC)
  • Other

    Common Stock

    2019-03-18+52213,439 total
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.67 to $27.94. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F2]The Reporting Person is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of DP VII Associates, L.P. Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities owned by each such entity, however he disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.
  • [F3]Distribution-in-kind of shares by One Palmer Square Associates VII, LLC, pro rata to its members.
  • [F4]The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT